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Abstract: BACKGROUND Invasive aspergillosis of the central nervous system is a rare but increasingly
prevalent disease. We present the unusual case of an immunosuppressed patient suffering from unex-
pected superinfected invasive aspergillosis with cerebral, pulmonal, and adrenal manifestations, mimick-
ing a metastasized bronchial carcinoma. This report reveals the importance of including aspergillosis
in the differential diagnosis of a cerebral mass lesion in the light of unspecific clinical findings. CASE
PRESENTATION A 58-year-old immunocompromised female presented to our emergency department
with a single tonic-clonic seizure. Imaging showed a ring enhancing cerebral mass with perifocal edema
and evidence of two smaller additional hemorrhagic cerebral lesions. In the setting of a mass lesion in the
lung, and additional nodular lesions in the left adrenal gland the diagnosis of a metastasized bronchus
carcinoma was suspected and the cerebral mass resected. However, histology did not reveal any evi-
dence for a neoplastic lesion but septate hyphae consistent with aspergillus instead and microbiological
cultures confirmed concomitant staphylococcal infection. CONCLUSIONS A high index of suspicion for
aspergillus infection should be maintained in the setting of immunosuppression. Clinical and radiological
findings are often unspecific and even misleading. Definite confirmation usually relies on tissue diagnosis
with histochemical stains. Surgical resection is crucial for establishing the diagnosis and guiding therapy
with targeted antifungal medications.
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Abstract
Background: Invasive aspergillosis of the central nervous system is a rare but increasingly prevalent disease. We
present the unusual case of an immunosuppressed patient suffering from unexpected superinfected invasive
aspergillosis with cerebral, pulmonal, and adrenal manifestations, mimicking a metastasized bronchial carcinoma.
This report reveals the importance of including aspergillosis in the differential diagnosis of a cerebral mass lesion in
the light of unspecific clinical findings.
Case presentation: A 58-year-old immunocompromised female presented to our emergency department with a
single tonic-clonic seizure. Imaging showed a ring enhancing cerebral mass with perifocal edema and evidence of
two smaller additional hemorrhagic cerebral lesions. In the setting of a mass lesion in the lung, and additional
nodular lesions in the left adrenal gland the diagnosis of a metastasized bronchus carcinoma was suspected and
the cerebral mass resected. However, histology did not reveal any evidence for a neoplastic lesion but septate
hyphae consistent with aspergillus instead and microbiological cultures confirmed concomitant staphylococcal
infection.
Conclusions: A high index of suspicion for aspergillus infection should be maintained in the setting of
immunosuppression. Clinical and radiological findings are often unspecific and even misleading. Definite
confirmation usually relies on tissue diagnosis with histochemical stains. Surgical resection is crucial for establishing
the diagnosis and guiding therapy with targeted antifungal medications.
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Background
Invasive aspergillosis of the central nervous system is a
rare disease, particularly in the Western World. How-
ever, in recent years this entity has become more fre-
quently diagnosed, particularly in immunocompromised
patients [1, 2]. Therefore, it is important to include
aspergillosis in the potential differential diagnosis of
cerebral mass lesion, even in the light of unspecific clin-
ical findings. In this article, we present the unusual case
of an immunosuppressed patient suffering from unex-
pected superinfected invasive aspergillosis with cerebral,
pulmonal, and adrenal manifestations, mimicking a me-
tastasized bronchial carcinoma.
Case presentation
A 58-year-old female presented to our emergency de-
partment with new-onset, generalized tonic-clonic
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seizures controlled by the administration of midazolam
and levetiracetam. Her past medical history included a
kidney transplantation due to a focal-segmental glomer-
ulosclerosis six months prior to admission, which was
treated with immunosuppressive therapy (mycopheno-
late, prednisone and tacrolimus). In addition, she re-
ceived levothyroxine substitution after a total
thyroidectomy for papillary thyroid cancer 3.5 years ago
and she was treated with amlodipine and metoprolol for
mild to moderate mitral insufficiency.
On admission, her vital signs were within normal
range. An initial aphasia resolved completely within a
few hours, and she did not show any focal deficits on
neurological examination. A computed tomography
(CT) scan of her head revealed a space-occupying lesion
in the left parietal lobe. Subsequent magnetic resonance
imaging (MRI) tomography of the brain confirmed a
ring enhancing mass with central diffusion restriction
and perifocal edema in the inferior parietal lobule
(Fig. 1). In addition, two smaller, hemorrhagic lesions
were visible in the postcentral gyrus and in the centrum
semiovale on the right side. In the absence of any clinical
evidence of inflammation and unremarkable cerebro-
spinal fluid (CSF) analysis, brain metastasis was consid-
ered the most likely differential diagnosis. Accordingly,
staging CT (thorax-abdomen) showed a mass lesion in
the right upper lobe of the lung, suspicious of bronchial
carcinoma. Additional nodular lesions were seen in the
left adrenal gland. Clinically, the patient remained stable
under antiepileptic therapy. However, follow-up MRI,
four days after the initial examination, showed progres-
sion of the left hemispheric lesion and the perifocal
edema.
Interdisciplinary consensus was urgent resection of
the symptomatic brain lesion, which would also en-
able a definitive diagnosis. A left parietal craniotomy
was performed, and the superficial mass was com-
pletely resected. Macroscopically, the lesion appeared
firm and indurated without any evidence of pus or
necrosis. However, histology did not reveal any evi-
dence for a neoplastic lesion. Instead, a collagenous
abscess wall containing mixed inflammatory cells, in-
cluding abundant neutrophils. The Grocott stain con-
firmed the presence of branched, septate hyphae
consistent with aspergillus (Fig. 2). Panfungal poly-
merase chain reaction (PCR) linked immunosorbent
assay of the resected specimen and fungal cultures
remained negative. In view of the clear histological
diagnosis of aspergillosis, additional galactomannan
antigen tests were not performed.
Fig. 1 Pre-operative axial MRI findings. Diffusion-weighted images (a), with corresponding ADC-map (b), showed a diffusion restricted left parietal
lesion. On T2-weighted images (c) the lesion appeared T2-hyperintense, with both a T2-hypointense central region and thin rim. The lesion
showed intense ring-enhancement in the T1-weighted contrast-enhanced images (d) and was surrounded by marked perifocal edema (c)
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The postoperative course was uneventful. Thera-
peutically, voriconazole was initiated, and due to sub-
therapeutic drug values complemented by
amphotericin B. However, the patient developed ser-
ious side effects (fever, shivering, nausea and vomitus)
from amphotericin B whereupon the antifungal ther-
apy was adapted to isavuconazole which was well tol-
erated. Initially, the patient received postoperative
empiric antibiotics (ceftriaxone and metronidazole),
which were adapted to flucloxacilline and metronida-
zole after microbiological cultures confirmed growth
of staphylococcus warneri and pasteuri species. A
positron emission tomography (PET)-CT scan showed
metabolically active lesions in the right upper lung
and left adrenal gland. Because of the yet unclear eti-
ology, interdisciplinary board suggested a video-
assisted thoracoscopic surgery (VATS) wedge resec-
tion of the right upper lung lobe for diagnostic and
therapeutic reasons. Pathological analysis of this tissue
confirmed the diagnosis of aspergillus fumigatus al-
though microbiological cultures remained negative.
Accordingly, a diagnosis of invasive aspergillosis with
cerebral, pulmonal and adrenal manifestations was
rendered. Over the course, antibiotics were deesca-
lated to clindamycin, antifungal regime was continued
with isavuconazole, and the patient discharged.
Discussion and conclusion
We present the unusual case of an immunosup-
pressed patient suffering from unexpected superin-
fected invasive aspergillosis with cerebral, pulmonal,
and adrenal manifestations, mimicking a metastasized
bronchial carcinoma.
Central nervous system (CNS) infections with asper-
gillus are rare and potentially fatal [3, 4]. Microscop-
ically, aspergillus species are characterized by
dichotomous branching, septated hyphae [1]. The pri-
mary acquisition route for acquiring aspergillus is the
inhalation of fungal conidia, which are spores that
subsequently reach the upper and lower respiratory
tract. Therefore, the paranasal sinus and the lungs are
the most common sites of primary aspergillus infec-
tion [2]. However, 40% of patients develop extrapul-
monary manifestation, with 10–20% demonstrating
CNS involvement [4]. The most important risk factors
for brain infections are neutropenia and corticosteroid
Fig. 2 Pathological staining of resected tumor. Histology reveals an abscess containing fungal hyphae surrounded by a collagenous wall. a H&E
stain shows the abscess wall containing mixed inflammatory cells, including abundant neutrophils. b Higher magnification is indicated by the
white square in a. Hyphae are visible within the abscess wall c Elastica-van-Gieson stain demonstrates the collagenous abscess capsule. d Grocott
silver stain illustrates septate hyphae branching at right angles, consistent with aspergillus
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use. In addition, immunocompromised, organ trans-
plant recipients, oncological, hematological, and ac-
quired immune deficiency syndrome patients are at
higher risk [2, 4]. Neuroaspergillosis may develop due
to extension from the paranasal sinuses and mastoid
air cells or by direct penetration after cranial trauma
and operations. However, hematogenous dissemin-
ation from invasive lung infection is more common in
immunocompromised patients [3, 5]. In this popula-
tion, a mortality rate of > 90% has been reported [4].
Clinical symptoms of an aspergillus infection are un-
specific and depend on the location of the fungus. Pa-
tients may present with fever, headache, lethargy,
altered mental status, seizures, dizziness, gait disor-
ders or other focal neurological deficits [6]. Classic-
ally, CSF studies show mononuclear pleocytosis,
elevated proteins and normal to reduced glucose
values [5]. Microbiological diagnosis of CSF is limited
to culture because other methods such as PCR have
only been validated in serum and bronchoalveolar lav-
age specimens [3]. Galactomannan, a polysaccharide
antigen located in the cell wall of aspergillus can be
detected by enzyme-linked immunosorbent assay [7].
However, we did not perform galactomannan testing,
since the diagnosis was already established by hist-
ology. Brain imaging is often helpful in establishing
the diagnosis, although CT and MR findings are non-
specific. Ring-enhancing lesions are not uncommon,
but contrast enhancement may be completely absent.
Dural enhancement may occur with generalized men-
ingoencephalitis. On unenhanced T1-weighted MRI,
aspergillus foci usually appear hypo- to isointense and
hypointense on T2-weighted images. Areas of T1-high
signal intensity may also be seen in case of
hemorrhage. Hemorrhage occurs in approximately
25% of lesions [8, 9]. Furthermore, aspergillus hyphae
may invade the walls of small and large blood vessels
which results in initial thrombosis, leading to infarc-
tion or development of mycotic aneurysms. With re-
gard to therapy, there are only few reports of patients
surviving neuroaspergillosis with antifungal medica-
tions alone [2]. Importantly, surgical resection must
always be complemented with antimycotic medication.
The presented patient was receiving immunosuppres-
sive medications, including corticosteroids (after kidney
transplantation). Thus, she harbored an increased risk
for developing neuroaspergillosis. Her clinical findings
were limited to a single tonic-clonic seizure and imaging
features were nonspecific. The presented case illustrates
that despite the unspecific clinical findings, it is import-
ant to include fungal infections in the differential diag-
nosis, especially in the setting of immunosuppression
from whatever cause. Interestingly, the situation was
complicated by a concomitant bacterial infection. The
intraoperative findings were atypical in this regard and
only microbiological cultures revealed streptococcus in-
fection. Although superinfections are recognized in pa-
tients who are immunocompromised undergoing
surgery, the detection of a bacterial infection may fur-
ther confound establishing the definitive diagnosis, as in
the presented case. Panfungal PCR from CSF (samples
taken before starting the antibiotics) were negative. Al-
though PCR from CSF is considered an experimental
diagnostic methodology, it may prove helpful in certain
cases. In the present case, however, the definitive diag-
nosis of aspergillus infection could only be established
after histological examination of the resected mass,
which is considered the gold standard.
In conclusion, invasive aspergillosis of the CNS is a
rare but increasingly prevalent disease, especially in im-
munocompromised patients. The infection may be iso-
lated or combined with other infectious diseases.
Accordingly, a high index of suspicion should be main-
tained in the setting of immunosuppression. Clinical and
radiological findings are often unspecific and even mis-
leading. Definite confirmation usually relies on tissue
diagnosis with histochemical stains. Surgical resection is
crucial for establishing the diagnosis and guiding therapy
with targeted antifungal medications.
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